Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality - Concepedia

Concepedia

Publication | Open Access

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

DOI Full Paper Access

293

Citations

18

References

2013

Year

Boikanyo Makubate, Peter T. Donnan, J A Dewar, A.M. Thompson, Colin McCowan

British Journal of Cancer

Abstract

Low adherence to all adjuvant endocrine therapy for women with breast cancer, whether tamoxifen or AI, increases the risk of death.

References

	Year	Citations
Adherence to Medication Lars Osterberg, Terrence F. Blaschke New England Journal of Medicine	2005	7.8K
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials The Lancet Breast OncologyMedicineRandomised TrialsPatient-level Meta-analysisPharmacology	2011	3K
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Jack Cuzick, Ivana Šestak, Michael Baum, The Lancet Oncology Breast OncologyOncologyAtac TrialPharmacologyAdjuvant Treatment	2010	1.7K
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer Dawn L. Hershman, Theresa Shao, Lawrence H. Kushi, Breast Cancer Research and Treatment NursingEarly DiscontinuationSurgical OncologyBreast OncologyMedicine	2010	868
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao, Journal of Clinical Oncology	2010	811
Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer Ann H. Partridge, Philip S. Wang, Eric P. Winer, Journal of Clinical Oncology	2003	671
Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer Ann H. Partridge, Andrea LaFountain, Erica L. Mayer, Journal of Clinical Oncology	2008	483
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial Cornelis JH van de Velde, Daniel Rea, Caroline Seynaeve, The Lancet Breast OncologyOncologyEarly Breast CancerMedicineRandomised Phase 3	2011	375
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer Colin McCowan, Jennifer Shearer, Peter T. Donnan, British Journal of Cancer NursingBreast OncologyCancer EpidemiologyHealth PolicyMedicine	2008	338
Adjuvant Tamoxifen: Predictors of Use, Side Effects, and Discontinuation in Older Women Serkalem Demissie, Rebecca A. Silliman, Timothy L. Lash Journal of Clinical Oncology	2001	299

Page 1